Somatotropic research compounds
Growth hormone-releasing hormone (GHRH) analogues studied in preclinical and clinical research for their effects on GH secretion, IGF-1 pathway activity, and downstream metabolic signalling.
This category includes CJC-1295 (no DAC), a GRF(1-29) analogue that produces a shorter, more physiologically pulsatile GH-release pattern, and Tesamorelin, one of the most clinically researched GHRH analogues, studied for both GH/IGF-1 pathway effects and visceral fat distribution in specific patient populations.
For in vitro research use only. Compounds in this category are not for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.
Compounds in somatotropic research
Research bundles containing somatotropic research compounds
STACK IMAGESomatotropic Research Bundle
STACK IMAGE